Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00340392 · ClinicalTrials.gov registry record
Isolation and Characterization of Mammary Stem Cells
A clinical trial, sponsored by National Cancer Institute (NCI).
- Completed
- Registry status
- 400
- Enrollment target
NCT00340392: Completed study, sponsored by National Cancer Institute (NCI).
NCT00340392 is a clinical trial that has completed, run by National Cancer Institute (NCI). The registered enrollment target is 400 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00340392 has completed, sponsored by National Cancer Institute (NCI).
- COMPLETED
- Registry status
- 400 participants
- Enrollment target
Study Summary
Background: * Cancer stem cells in breast cancer have been identified as a small population of tumor cells whose self-renewal mechanism is highly deregulated. This deregulation seems to be necessary for cancer to develop. * These cells can be identified by certain surface markers that overlap with markers associated with normal embryonic stem cells. Objective: To isolate tumor stem cells using the same methods generally used to isolate human embryonic stem cells. Eligibility: * Tissue samples will be obtained from the human cooperative network. * Samples will include normal tissues from individuals who have no opportunistic diseases and from individuals with cancer. Design: Breast cancer stem cells will be isolated, grown in the laboratory and characterized.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 400 participants |
| Start Date | 2006-04-07 |
| Est. Completion | 2011-03-23 |
What the finished NCT00340392 record still lists
NCT00340392 is an observational study that tracks outcomes without assigning an intervention. The registered 400 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT00340392 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00340392 about?
NCT00340392 is a clinical study titled "Isolation and Characterization of Mammary Stem Cells". Background: * Cancer stem cells in breast cancer have been identified as a small population of tumor cells whose self-renewal mechanism is highly deregulated. This deregulation seems to be necessary for cancer to develop. * These cells can be identified by certain surface markers that overlap with ...
What is the current status of trial NCT00340392?
This trial is currently completed. The enrollment target is 400 participants. The study started on 2006-04-07. Estimated completion is 2011-03-23.
Who is sponsoring clinical trial NCT00340392?
This trial is sponsored by National Cancer Institute (NCI), which has 3,257 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01665326 · 400 participants
Determination of CRIM Status and Longitudinal Follow-up of Individuals With Pompe Disease
- NCT02108054 · 400 participants · NA
Behavioral and Functional Task Development, Implementation, and Testing
- NCT02216500 · 400 participants · NA
Ketogenic Therapy Effects on Electrical and Metabolic Abnormalities in Epilepsy
- NCT02250352 · 400 participants
Core Biopsies for Establishing a Breast Tumor Tissue Repository
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI